Reverse genetics of influenza virus

Virology

Volumn 287, Issue 2, 2001, Pages 243-250

  Neumann, Gabriele ^a   Kawaoka, Yoshihiro ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA;

BIOTECHNOLOGY; GENE TECHNOLOGY; INFLUENZA VIRUS; MOLECULAR CLONING; NONHUMAN; PLASMID; PRIORITY JOURNAL; RNA SYNTHESIS; RNA VIRUS; SHORT SURVEY; VIRAL GENETICS; VIRUS GENOME;

INFLUENZA VIRUS; RNA VIRUSES;

EID: 0035450506     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1008     Document Type: Article

References (63)

1. Influenza B viruses with site-specific mutations introduced into the HA gene
2. Rescue of rinderpest virus from cloned cDNA
3. Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5′ capped end
4. Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: A review
5. Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs
6. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter
7. Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein
8. Rescue of mumps virus from cDNA
9. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development
10. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2)
11. Recovery of infectious human parainfluenza virus type 3 from cDNA
12. Introduction of site-specific mutations into the genome of influenza virus
13. High-efficiency formation of influenza virus transfectants
14. An influenza virus containing nine different RNA segments
15. Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs
16. Resuce of influenza A virus from recombinant DNA
17. Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus
18. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: Generation of a novel copy-back nondefective interfering virus
19. Establishment of a rescue system for canine distemper virus
20. Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa
21. Efficient formation of influenza virus-like particles: Dependence on the expression levels of viral proteins
22. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses
23. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene
24. Sequence comparison of A/AA/6/60 influenza viruses: Mutations which may contribute to attenuation
25. A DNA transfection system for generation of influenza A virus from eight plasmids
26. Unidirectional RNA polymerase I-polymerase II transcription system for the generation of influenza A virus from eight plasmids
27. An infectious clone of human parainfluenza virus type 3
28. Purification and molecular structure of RNA polymerase from influenza virus A/PR8
29. Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus
30. Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV
31. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense
32. Orthomyxoviridae: The viruses and their replication
33. Recombinant vesicular stomatitis viruses from DNA
34. Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1
35. + T-cell-mediated protective immunity against malaria
36. Electroporation of influenza virus ribonucleoprotein complexes for rescue of the nucleoprotein and matrix genes
37. Amplification, expression and packaging of a foreign gene by influenza virus
38. The development of live attenuated cold-adapted influenza virus vaccine for humans
39. Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids
40. Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS
41. Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus
42. Mutational analysis of influenza virus promoter elements in vivo
43. RNA polymerase I-mediated expression of influenza viral RNA molecules
44. Generation of influenza A viruses entirely from cloned cDNAs
45. Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1
46. Plasmid-driven formation of influenza virus-like particles
47. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins
48. Promoter analysis of influenza virus RNA polymerase
49. Rescue of Newcastle disease virus from cloned cDNA: Evidence that cleavability of the fusion protein is a major determinant for virulence
50. Reverse genetic of negative-strand RNA viruses: Closing the circle
51. Expression of a foreign protein by influenza A virus
52. A plasmid-based reverse genetics system for influenza A virus
53. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription
54. Rescue of measles virus from cloned DNA
55. Recovery of negative-strand RNA viruses from plasmid DNAs: A positive approach revatilizes a negative field
56. Generation of recombinant lentogenic Newcastle disease virus from cDNA
57. Isolation and characterization of a transfectant influenza B virus altered in RNA segment 6
58. Infectious rabies viruses from cloned cDNA
59. Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation
60. Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity
61. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones
62. Growth control of influenza A virus by M1 protein: Analysis of transfectant viruses carrying the chimeric M gene
63. Membrane-anchored incorporation of a foreign protein in recombinant influenza virions